This marks the first and only antibody drug conjugate in India with a tumour-agnostic indication, representing a significant advancement in precision oncology, the company said. Continue reading AstraZeneca gets nod to market cancer drug in India
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best stocks to buy under $20. On October 1, BioCryst Pharmaceuticals announced the successful completion of the previously announced sale of its European ORLADEYO (berotralstat) business to Neopharmed Gentili. The transaction is valued at $250 million upfront, subject to customary purchase price adjustments, with the potential for […] Continue reading BioCryst Sells European ORLADEYO Business for $250M Upfront to Focus on US Market
In 2025, India and China are cautiously strengthening economic ties, with bilateral trade reaching $127.7 billion, as major Indian firms, like Sun Pharma and Tata Motors, collaborate with Chinese companies in various sectors. Continue reading These large Indian companies are currently collaborating with Chinese firms